最后更新: 8 月 25, 2026
Prostate cancer is among the commonest cancers diagnosed in men, and most of the cancers found are slow-growing. It causes no symptoms in its early stages, which is why it is looked for with a blood test rather than waiting for something to go wrong. Men understandably want to know whether anything they do can lower their risk — and one particular study gets quoted more than any other in answer.
It is worth looking at properly, because it is more interesting and considerably weaker than the headlines suggest.

What the study found
A large prospective cohort study from the United States, published in 2016, followed nearly 32,000 men for eighteen years and asked them how often they ejaculated in their twenties and again in their forties.
- Typical frequency in the group was around 8 to 12 times a month.
- Men reporting 21 or more times a month had a modestly lower rate of prostate cancer than men reporting the least.
- The association was seen for low- and intermediate-risk disease.
- No association was seen with aggressive, high-risk cancer — the form that causes almost all the deaths.
Why this is not the same as a preventive measure
An earlier version of this article carried a caveat in the text saying the evidence was observational — and then answered yes, frequent ejaculation reduces prostate cancer risk in its own FAQ. The two contradicted each other, and the FAQ has been corrected. That matters, because the FAQ is the part search engines quote.
Three specific problems sit between this association and any claim of cause and effect:
- Sexual frequency travels with everything else. Men who ejaculate more often tend to be healthier, more likely to have a partner, less depressed, and to have higher testosterone. Any of those could be doing the work, and no statistical adjustment fully separates them.
- Cause and effect may run backwards. Prostate disease reduces sexual function years before it is diagnosed. Some of the men in the lowest-frequency group may have had low frequency because of an undetected prostate problem, rather than developing one because of low frequency.
- What it counts is diagnoses, not disease. The association concerns the low-risk cancers that are largely found by screening — many of which would never have harmed anyone. A difference in how often such cancers are detected is not the same as a difference in how often men get ill.
The most telling point is the last line of the findings. Whatever the association represents, it does not touch aggressive prostate cancer — which is the only kind that determines whether a man lives or dies of this disease.

So what should a man take from it?
Something reassuring, and not a target. There is no reason to think a normal sex life carries any prostate risk, and this study is decent evidence that it does not — a question men genuinely worry about and are often too embarrassed to ask. That is worth saying plainly.
What it is not is a number to hit. Treating 21 a month as a prescription reads far more into observational data than it can carry, and a man who cannot reach it has not failed at anything. An earlier version of this article presented the figure as actionable advice; it is better understood as a description of the group in whom the association was strongest.
The factors with better evidence behind them for cancer outcomes generally remain the dull ones — not smoking, keeping weight down, staying active — and they act on heart disease at the same time, which is what will actually kill most men. See also diet and prostate cancer, ,和 what the evidence on lycopene really supports.
And about screening
Nothing described here changes the screening question, and the earlier version of this article overstated it by presenting PSA testing as a routine part of a health check for men over fifty.
Whether to have a PSA test is a decision, not a default. It depends on age, family history, ethnicity, general health, and — most of all — on what a man would want done with an abnormal result, since PSA testing leads to biopsies and to the detection of cancers that would never have caused trouble. It is a conversation worth having properly rather than a box to tick. That discussion is set out in should I have a PSA test.
Symptoms that need assessment regardless
None of the above applies to a man who already has symptoms. In an emergency in Thailand, call 1669.
- Visible blood in the urine or in the semen.
- New bone pain, particularly in the back, hips or ribs.
- Unexplained weight loss.
- Inability to pass urine with a painful full bladder — this needs same-day treatment.
- A PSA result you have been given and do not understand. Bring the number itself and any previous readings.
常见问题解答
Does frequent ejaculation reduce the risk of prostate cancer?
It has not been shown to. A large observational study found that men reporting the highest ejaculation frequency developed low- and intermediate-risk prostate cancer somewhat less often, but an association of that kind cannot establish cause and effect — sexual frequency travels alongside general health, partnership and testosterone, and early prostate disease itself reduces sexual activity years before diagnosis. An earlier version of this article answered this question with a plain yes, which was too strong.
Is 21 times a month a target I should aim for?
No. That figure describes the group in whom the association was strongest in one study; it is not a prescription and there is no evidence that reaching a particular count changes anything. A man whose frequency is lower has not done anything wrong.
Does it protect against aggressive prostate cancer?
No association was found with high-risk disease — which is the form responsible for almost all deaths from prostate cancer. This is the single most important limitation of the finding.
Should I have a PSA test?
That is a decision to make deliberately rather than a routine part of a health check. It depends on your age, family history, general health and what you would want done with an abnormal result, because PSA testing leads to biopsies and to finding cancers that would never have caused harm. An earlier version of this article presented it as a routine recommendation for men over fifty, which has been corrected.
Is there any prostate risk from a very active sex life?
There is no evidence of harm, and this study is reasonable reassurance on that point. Men ask about it far more often than they admit, and the answer is that a normal sex life at any frequency is not a prostate risk.
安排咨询
For a PSA discussion or prostate assessment, Dr. Soarawee Weerasopone sees patients at 曼谷医院总部 并在春武里府的三美泰是拉查医院 088-022-1445. Bring every previous PSA result with its date — the trend over time says more than any single number.
曼谷医院远程医疗服务适用于无法亲自就诊的患者,包括国际患者——请通过电子邮件提前向泌尿科预约: bhquro@bdms.co.th. 三美泰是拉差医院(Samitivej Sriracha)仅提供线下就诊服务。有关费用事宜,请直接向医院咨询,本网站不予解答。.
免责声明 本文由曼谷医院总院的认证泌尿科医师Soarawee Weerasopone博士撰写和审核,仅供教育目的使用。它并非医疗建议、诊断或针对任何个人的处方,且不会通过私人消息渠道或社交媒体提供任何建议、诊断或处方。Soarawee博士没有运营任何公开的社交媒体账号;任何以他的名义提供私人咨询的账号均为诈骗。如果在泰国遇到紧急情况,请拨打 1669.
医学撰写与审核:Soarawee Weerasopone 医生(Pom 医生)——曼谷医院总院认证泌尿科医师,自 2016 年起从事泌尿外科临床工作。进修:台湾长庚纪念医院机器人手术学(2019 年) · 临床观察员:东京顺天堂大学附属医院泌尿内视镜学(2022 年) · 研究学者与临床观察员:美国贝勒医学院斯科特泌尿外科系(2025–2026 年)。.

Soarawee Weerasopone 医生(Dr. Pom)是 Bangkok Hospital Headquarters 的委员会认证泌尿科医生,专长于男性健康、机器人手术(da Vinci Xi)及肾结石治疗。他目前在贝勒医学院 Scott 泌尿外科担任研究学者及临床观察员(2025–2026),师从 Mohit Khera 教授。他曾在台湾长庚纪念医院完成机器人外科研修(fellowship,2019年),并在东京顺天堂大学医院完成腔内泌尿外科临床观摩(observership,2022年)。

